June 30th, 2010 |
Published in
Healthy Meals
AstraZeneca Plc , the U.K.’s second- largest drugmaker, won a U.S. court ruling that prevents generic-drug makers from selling lower-cost copies of its cholesterol medicine Crestor until 2016.
Read this article:
AstraZeneca, WebTech, Vermillion, Playboy, LVMH: Intellectual Property
February 18th, 2010 |
Published in
Healthy Meals
s Lipitor, AstraZeneca’s Plc’s Crestor, and rival drugs to lower cholesterol also boost diabetes rates by about 9 percent, according to a study that quantified a complication that doctors only recently discovered. Manufacturers of pacemakers, drug …
Link:
Today’s Globe – Boston Globe
Tags:
also-boost,
and-rival,
astra,
cholesterol,
crestor,
diabetes-rates,
drug,
lipitor,
lower-cholesterol,
only-recently,
recently-discovered
February 11th, 2010 |
Published in
Healthy Meals
LONDON, Feb 11 (Reuters) – AstraZeneca expects use of its blockbuster heart drug Crestor to grow substantially over the next 12 months on the back of an expanded label granted by the U.S. Food and Drug Administration this week
Here is the original post:
INTERVIEW-UPDATE 1-Astra CEO shrugs off Crestor doubters – Forex Pros
February 10th, 2010 |
Published in
Healthy Meals
WEDNESDAY, Feb. 10 (HealthDay News) — U.S. Food and Drug Administration approval for Crestor (rosuvastatin) has been widened to include people who have no obvious symptoms of heart disease, Dow Jones reported.
The rest is here:
Crestor Approval Expanded – Metapsychology
February 10th, 2010 |
Published in
Healthy Meals
Federal regulators have granted AstraZeneca approval to market its cholesterol pill Crestor as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels. The Food and Drug Administration decision will allow the …
Read more from the original source:
Genzyme, Isis say cholesterol drug met trial goal – Tacoma News Tribune
Tags:
against-heart,
allow-the,
astra,
attack-and,
crestor,
decision-will,
healthy-cholesterol,
market-its,
patients-with,
preventive-measure,
regulators-have
February 10th, 2010 |
Published in
Healthy Meals
February 10th, 2010 |
Published in
Healthy Meals
The Food and Drug Administration (FDA) has approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease even though they have not been diagnosed with it.
Go here to read the rest:
FDA Approves New Use for Crestor – consumer affairs.com
Tags:
approved-the-cholesterol,
cholesterol,
crestor,
diagnosed-with,
even-though,
fda,
for,
for-some,
has-approved,
heart-disease,
new-indication,
not-been,
the-cholesterol-lowering
February 9th, 2010 |
Published in
Healthy Meals
Tags:
approved-the,
approved-the-cholesterol,
but-have,
cholesterol,
crestor,
diagnosed-with,
for-reducing,
for-some,
heart-disease,
increased-risk,
new-indication,
not-been
February 9th, 2010 |
Published in
Healthy Meals
WASHINGTON — Federal regulators have granted AstraZeneca approval to market its cholesterol pill Crestor as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels.
The rest is here:
FDA approves expanded use for Crestor – Courier-Post
Tags:
against-heart,
attack-and,
cholesterol,
crestor,
decision,
federal,
healthy-cholesterol,
market-its,
patients-with,
preventive-measure,
regulators-have
February 9th, 2010 |
Published in
Healthy Meals
The FDA has granted approval to market Crestor in patients with healthy cholesterol levels but increased risk of cardiovascular disease. Washington, February 9 — AstraZeneca (LSE: AZN) has got the green signal by federal regulators to market its …
The rest is here:
FDA clears anti-cholesterol pill Crestor – The Money Times